Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34 Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 815K
2: EX-23.1 Consent of Experts or Counsel HTML 28K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 24K
53: R1 Document and Entity Information HTML 42K
41: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 112K
51: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 38K
(Parenthetical)
55: R4 Condensed Consolidated Statements of Operations HTML 109K
(Unaudited)
74: R5 Condensed Consolidated Statements of Comprehensive HTML 51K
Income (Loss) (Unaudited)
43: R6 Condensed Consolidated Statements of Cash Flows HTML 185K
(Unaudited)
50: R7 Condensed Consolidated Statements of Cash Flows HTML 26K
(Unaudited) (Parenthetical)
37: R8 Business and Organization HTML 34K
28: R9 Summary of Significant Accounting Policies HTML 74K
75: R10 Earnings (Loss) Per Share HTML 80K
57: R11 Composition of Certain Financial Statement HTML 140K
Captions
56: R12 Acquisitions, Investments, and Licenses HTML 147K
62: R13 Debt HTML 126K
63: R14 Accumulated Other Comprehensive Income (Loss) HTML 44K
60: R15 Fair Value Measurements HTML 177K
64: R16 Derivative Contracts HTML 100K
52: R17 Related Party Transactions HTML 39K
54: R18 Commitments and Contingencies HTML 37K
59: R19 Strategic Alliances HTML 45K
80: R20 Segments HTML 164K
69: R21 Subsequent Events HTML 35K
47: R22 Summary of Significant Accounting Policies HTML 136K
(Policies)
58: R23 Earnings (Loss) Per Share (Tables) HTML 72K
49: R24 Composition of Certain Financial Statement HTML 141K
Captions (Tables)
21: R25 Acquisitions, Investments, and Licenses (Tables) HTML 126K
71: R26 Debt (Tables) HTML 102K
77: R27 Accumulated Other Comprehensive Income (Loss) HTML 40K
(Tables)
32: R28 Fair Value Measurements (Tables) HTML 174K
31: R29 Derivative Contracts (Tables) HTML 100K
35: R30 Segments (Tables) HTML 155K
36: R31 Business and Organization (Details) HTML 44K
38: R32 Summary of Significant Accounting Policies HTML 103K
(Details)
19: R33 Earnings (Loss) Per Share (Details) HTML 62K
67: R34 Earnings (Loss) Per Share - Narrative (Details) HTML 36K
45: R35 Composition of Certain Financial Statement HTML 155K
Captions (Details)
48: R36 Composition of Certain Financial Statement HTML 70K
Captions - Changes in Goodwill (Details)
24: R37 Acquisitions, Investments, and Licenses - HTML 98K
Acquisition Narrative (Details)
79: R38 Acquisitions, Investments, and Licenses - Schedule HTML 115K
of Purchase Price Allocation (Details)
13: R39 Acquisitions, Investments, and Licenses - Schedule HTML 35K
of Pro Forma (Details)
39: R40 Acquisitions, Investments, and Licenses - Summary HTML 38K
of Investments (Details)
73: R41 Acquisitions, Investments, and Licenses - Equity HTML 56K
Method Investments Narrative (Details)
23: R42 Acquisitions, Investments, and Licenses - HTML 51K
Available for Sale Investments, Sale of
Investments and Warrants and Options Narrative
(Details)
30: R43 Acquisitions, Investments, and Licenses - Variable HTML 91K
Interest Entities Narrative (Details)
34: R44 Acquisitions, Investments, and Licenses - Schedule HTML 83K
of Consolidated Assets and Non-Recourse
Liabilities (Details)
42: R45 Debt - Narrative (Details) HTML 179K
18: R46 Debt - Notes (Details) HTML 53K
27: R47 Debt - Inputs Used In Lattice Model (Details) HTML 44K
15: R48 Debt - Fair Value Of Embedded Derivatives HTML 30K
(Details)
72: R49 Debt - Lines Of Credit (Details) HTML 59K
22: R50 Debt - Mortgage Notes And Other Debt (Details) HTML 35K
68: R51 Accumulated Other Comprehensive Income (Loss) HTML 46K
(Details)
25: R52 Fair Value Measurements - Summary Of Investments HTML 43K
(Details)
40: R53 Fair Value Measurements - Assets And Liabilities HTML 68K
Measured At Fair Value (Details)
14: R54 Fair Value Measurements - Notes (Details) HTML 30K
17: R55 Fair Value Measurements - Level 3 Reconciliation HTML 39K
(Details)
33: R56 Fair Value Measurements - Narrative (Details) HTML 45K
20: R57 Derivative Contracts - Balance Sheet Component HTML 43K
(Details)
76: R58 Derivative Contracts - Derivative Gains (Losses) HTML 34K
(Details)
44: R59 Derivative Contracts - Outstanding Forward HTML 62K
Contracts (Details)
61: R60 Related Party Transactions (Details) HTML 158K
26: R61 Commitments and Contingencies (Details) HTML 35K
29: R62 Strategic Alliances (Details) HTML 100K
66: R63 Segments - Narrative (Details) HTML 50K
65: R64 Segments (Details) HTML 86K
46: R65 Subsequent Events (Details) HTML 86K
78: XML IDEA XML File -- Filing Summary XML 142K
16: EXCEL IDEA Workbook of Financial Reports XLSX 121K
7: EX-101.INS XBRL Instance -- opk-20150930 XML 3.53M
9: EX-101.CAL XBRL Calculations -- opk-20150930_cal XML 237K
10: EX-101.DEF XBRL Definitions -- opk-20150930_def XML 1.20M
11: EX-101.LAB XBRL Labels -- opk-20150930_lab XML 2.15M
12: EX-101.PRE XBRL Presentations -- opk-20150930_pre XML 1.43M
8: EX-101.SCH XBRL Schema -- opk-20150930 XSD 206K
70: ZIP XBRL Zipped Folder -- 0000944809-15-000014-xbrl Zip 354K
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant Section 906 of the Sarbanes-Oxley Act of 2002, I, Phillip Frost, Chief Executive Officer of OPKO Health, Inc. (the “Company”), hereby certify that:
The Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2015 (the “Form 10-Q”) of the Company fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
